Cargando…
Podocalyxin in Normal Tissue and Epithelial Cancer
SIMPLE SUMMARY: Malignancies derived from epithelial cells account for over 90% of all human cancers. Several aspects of cancer progression such as metastasis, immune evasion, and resistance to chemotherapy are often associated with poor prognosis and unfavourable patient outcomes due to limited the...
Autores principales: | Le Tran, Ngoc, Wang, Yao, Nie, Guiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227556/ https://www.ncbi.nlm.nih.gov/pubmed/34201212 http://dx.doi.org/10.3390/cancers13122863 |
Ejemplares similares
-
Podocalyxin promotes an impermeable epithelium and inhibits pro-implantation factors to negatively regulate endometrial receptivity
por: Heng, Sophea, et al.
Publicado: (2021) -
Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011) -
Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell
Publicado: (1984) -
Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015) -
Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling
por: Fröse, Julia, et al.
Publicado: (2018)